Community Practice

The increase in utilization of generic drugs is driving costs down, while the increase in specialty pharmacy utilization is driving costs up, according to the 2013 CVS Caremark annual Insights Report.

Will FDA classify hydrocodone as Schedule III, Schedule II, or somewhere in between?

Guideline-directed medical therapy for heart failure (HF) is highly cost-effective and able to produce significant health gains for individuals with mild to moderate disease, according a study published April 2 in the Journal of the American College of Cardiology.

First new NVP approval in 50 years brings back 30-year-old drug

The antiarrhythmia drug amiodarone appears to be linked to a higher risk of cancer in men, specifically those who receive higher cumulative defined daily doses within the first year of treatment, according to a retrospective study published online April 8 in Cancer.

Ruling clears obstacles judge said were politically influenced

Pharmacists and other healthcare providers are still confusing Prilosec (omeprazole) and Prozac (fluoxetine) prescriptions, according to a new report from the Institute for Safe Medication Practices (ISMP).

The IMS report tracked impact of care on Managed Medicaid beneficiaries in Kentucky, New Jersey, New York, and Ohio since 2011 in three therapeutic areas: antipsychotics, diabetes agents, and respiratory medications

Walgreens announced April 2 that it is expanding its Balance Rewards program to give extra points to customers for completing health-related activities.

NCPA responds to CMS' final call letter for 2014 PDPs

First winners of the "Pharmacy Is Right for Me Student Innovation Challenge" are announced

A review of the literature provides moderate strength evidence that sublingual immunotherapy is effective for the treatment of allergic rhinitis and asthma, according to an article published March 27 in the JAMA.

The third edition of APhA's pocket reference is now available

Diabetes drug canagliflozin (Invokana, Janssen Pharmaceuticals) is the first drug approved by the FDA in a new class known as sodium-glucose co-transporter 2 (SGLT2) inhibitors.

The use of extended-release niacin as an adjunct to statins does not reduce the risk of a heart attack or stroke in patients with pre-existing cardiovascular disease, according to researchers who led the HPS2-THRIVE study.

The third edition of "Peripheral Brain for the Pharmacist" is now available

Med Prep Consulting, Inc., a compounding pharmacy in Tinton Falls, NJ, is voluntarily recalling all lots of compounded products from its facility for fear of mold contamination, according to an FDA press release.

We've compiled a list of users to follow who provide news updates or offer opinions about the world of pharmacy.

While some aspects of pharmacy practice may drive you up a wall, there are customers who will make any day just a bit better

It's called the criminal justice system. There may be another term for it. A shorter one.